Author
Listed:
- Ulrika Norin
(Karolinska Institute)
- Carola Rintisch
(Karolinska Institute
Lund University
Max-Delbrück-Center for Molecular Medicine (MDC))
- Liesu Meng
(Karolinska Institute
Xi’an Jiaotong University Health Science Center)
- Florian Forster
(Karolinska Institute)
- Diana Ekman
(Karolinska Institute
Stockholm University)
- Jonatan Tuncel
(Karolinska Institute)
- Katrin Klocke
(Karolinska Institute)
- Johan Bäcklund
(Karolinska Institute)
- Min Yang
(Karolinska Institute)
- Michael Y. Bonner
(Karolinska Institute)
- Gonzalo Fernandez Lahore
(Karolinska Institute)
- Jaime James
(Karolinska Institute)
- Klementy Shchetynsky
(Karolinska Institute and Karolinska University Hospital)
- Maria Bergquist
(University of Gothenburg
Uppsala University)
- Inger Gjertsson
(University of Gothenburg)
- Norbert Hubner
(Max-Delbrück-Center for Molecular Medicine (MDC)
Charité-Universitätsmedizin Berlin)
- Liselotte Bäckdahl
(Karolinska Institute)
- Rikard Holmdahl
(Karolinska Institute
Xi’an Jiaotong University Health Science Center)
Abstract
The introduction of the CTLA-4 recombinant fusion protein has demonstrated therapeutic effects by selectively modulating T-cell activation in rheumatoid arthritis. Here we show, using a forward genetic approach, that a mutation in the SH3gl1 gene encoding the endocytic protein Endophilin A2 is associated with the development of arthritis in rodents. Defective expression of SH3gl1 affects T cell effector functions and alters the activation threshold of autoreactive T cells, thereby leading to complete protection from chronic autoimmune inflammatory disease in both mice and rats. We further show that SH3GL1 regulates human T cell signaling and T cell receptor internalization, and its expression is upregulated in rheumatoid arthritis patients. Collectively our data identify SH3GL1 as a key regulator of T cell activation, and as a potential target for treatment of autoimmune diseases.
Suggested Citation
Ulrika Norin & Carola Rintisch & Liesu Meng & Florian Forster & Diana Ekman & Jonatan Tuncel & Katrin Klocke & Johan Bäcklund & Min Yang & Michael Y. Bonner & Gonzalo Fernandez Lahore & Jaime James & , 2021.
"Endophilin A2 deficiency protects rodents from autoimmune arthritis by modulating T cell activation,"
Nature Communications, Nature, vol. 12(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-020-20586-2
DOI: 10.1038/s41467-020-20586-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-020-20586-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.